# Kolon Life Science signs KRW 16.9B supply deal for Invossa-K

Kolon Life Science has signed a 16.9 billion won supply contract with Zhong JI 1 International Medical Group for Invossa-K in Hong Kong and Macau. The contract is for five years.

- Type: Contract
- Announced: 2018-06-20
- Where: Hong Kong and Macau, Hong Kong SAR China
- Value: $15.0M (16.9B KRW)
- Status: announced
- Products: Invossa-K (gene therapy), cell therapy
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Kolon Life Science](https://endata.com/companies/32675.md)
- [Zhong JI 1 International Medical Group](https://endata.com/companies/32676.md) (customer)

## Sources

- [etoday.co.kr](https://www.etoday.co.kr/news/view/1633507), 2018-06-20: "코오롱생명과학은 169억원 규모 인보사-케이 주식회사 공급계약을 체결했다고 20일 공시했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.